Gylan® Ultradex Moisturizing Ophthalmic Solution (hereinafter – the solution, the product) is a colorless, slightly viscous solution.
Product version: Gylan® Ultradex.
Composition: Dexpanthenol 2% (16.0–24.0 mg/ml), Sorbitol (18.00–22.00 mg/ml), Disodium hydrogen phosphate dihydrate (7.48–9.14 mg/ml), Sodium dihydrogen phosphate dihydrate (2.83–3.45 mg/ml), Sodium hyaluronate 0.3% (3.0 ± 0.60 mg/ml), Water for injection (up to 1 ml).
The field of application is ophthalmology.
Gylan® Ultradex is intended for eye care by intraconjunctival instillation. Gylan® Ultradex ophthalmic moisturizing solution reproduces the action of natural tears, protects and moisturizes the ocular surfaces and lubricates them. This product has a long-term facilitary action on dry eyes caused by various factors:
Gylan® Ultradex is a sterile 0.3% aqueous sodium hyaluronate solution with 2% dexpanthenol, free of preservatives.
The active substance, highly purified sodium hyaluronate, is produced by bacterial fermentation. Sodium hyaluronate is a physiological polysaccharide compound found both in eye tissues and in other human tissues and fluids.
A specific physicochemical property of sodium hyaluronate molecules is their strong ability to bind water molecules. Its aqueous solution (GYLAN) has the necessary viscosity and strong adhesive properties, effectively moisturizing the eye surface.
The solution also contains provitamin B5 (dexpanthenol), which has high water-binding capacity, further moisturizing the eyes and enhancing the hydration effect of sodium hyaluronate. Dexpanthenol also has anti- inflammatory and wound-healing properties, supporting faster regeneration of the eyes after trauma and surgery.
When applied, Gylan® Ultradex forms a thin, even film on the corneal epithelium, protecting the eyes from dryness, irritation, and inflammation of the anterior eye surface. The protective film acts instantly and provides long-term protection from dryness, burning, foreign body sensation, and irritation caused by computer work, air conditioning, or environmental factors. The precorneal tear film formed after instillation remains stable for a long time, is not washed away by blinking, and does not impair visual acuity.
Adequate eye surface hydration with Gylan® Ultradex helps normalize physiological processes and accelerates healing after trauma and surgery. Gylan® Ultradex effectively and rapidly relieves symptoms of dry eye syndrome of varying severity: eliminates foreign body sensation, burning, and stinging, reduces fatigue from intense visual strain, relieves discomfort, and helps maintain healthy eyes.
For regular contact lens wear, the use of Gilan® Ultradex is recommended, as it provides prolonged eye hydration due to its action being identical to natural tear fluid. The solution makes wearing hard or soft contact lenses more comfortable without depositing on the lens surface.
Gilan® Ultradex contains no preservatives, thus avoiding undesirable toxic effects on eye tissues and is well tolerated even with long-term use.
It provides longer-lasting effects due to the higher sodium hyaluronate content and increased solution viscosity (9.0–25.0 mPa·s).
Thanks to the special dropper design, the solution remains sterile throughout its shelf life after opening. Sterility after opening is ensured by the dropper’s construction — a special spring prevents solution from returning into the bottle from the remaining content after instillation, thereby avoiding contact with external solution. A sterilizing multilayer filter membrane in the air channel of the dropper further ensures sterility.
There are no safety data on the use of Gylan® Ultradex solution during pregnancy and breast-feeding period.
Increased sensation to any of the components included in the Gylan®Ultradex solution.
Gylan® Ultradex ophthalmic moisturizing solution is instilled 1-2 drops into the conjunctival sac as the circumstances require to 6 times a day.
How to use a dropper tube (unidose):
How to use a bottle with a drop dispenser:
Gylan® Ultradex solution should not be used with damaged or opened packaging.
Possible allergic reactions.
A possible feeling of eyelids sticking together due to the solution viscosity.
In case of combined use with ophthalmic preparations it is recommended to observe a pause of at least 10 minutes between instillation of Gylan® Ultradex solution and application of eye drops.
Eye ointments should always be applied after instillation of Gylan® Ultradex solution.
Gylan® Ultradex does not belong to the products that can affect psychomotor state of a person.
It does not effect on ability to drive and use machines.
0.4 mL of solution in a dropper tube (unidose) of polyethylene or 10 mL in a bottle of polyethylene, complete with a drop dispenser.
5 or 10 dropper tubes or 1 bottle in a foil or metallized film bag (for a bottle – if necessary).
1, 2, 4, 6 or 8 bags with 5 dropper tubes or 1, 2, 3 or 4 bags with 10 dropper tubes, or 1 bag with a bottle complete with a drop dispenser, together with a patient information leaflet in a cardboard pack.
It is allowed to enclose 1 bottle without a bag together with a patient information leaflet in a cardboard pack.
It is allowed to enclose 1 dropper tube (unidose) on a cardboard tray in a foil or metallized film bag as a consumer package without patient information leaflet.
It is allowed to wrap the cardboard pack with polymer film.
Store at +2°С to +25°С.
Do not freeze.
Keep out of reach of children.
In a bottle – 3 years. After opening the bottle, the solution can be used for the entire shelf life.
In a dropper tube in a bag – 3 years. After opening the bag – 1 year.
Do not use after expiration date!
By all types of covered vehicles in accordance with the haulage rules, operating on each type of vehicle, at +2°C to +25°C. Do not freeze. Keep away from heat. Protect from moisture.
Grotex LLC, Russia
195279, St. Petersburg, Industrialniy Avenue, 71, building 2, lit. А
Tel.: +7 812 385 47 87
Fax: +7 812 385 47 88
www.solopharm.com
www.gylan.ru
Gylan® Ultradex ophthalmic moisturizing solution in dropper tubes (unidoses) or in a bottle with a drop dispenser is produced according to TS 21.20.23-027-64260974-2020 in compliance with international and
national standards.
Dropper tubes (unidoses) with a nominal volume of 0,5 mL ± 8% are made of polyethylene granules of Purell, Bormed, Eltex® MED, HLD01S, PE
MG013 R, SABIC® LDPE PCG06, BB120, complying with the current European Pharmacopoeia.
The full volume bottle of 13 ± 1 mL is made of low density polyethylene (LDPE) of Purell PE 1810 E, LDPE 15803-020, Purell PE 1840 H.
In terms of biological safety the solution meets the requirements of GOST ISO 10993 series of standards. The solution is biologically safe.
The solution is sterile. The solution is poured under aseptic conditions in accordance with GOST R ISO 13408-1.
The solution is intended for use in medical institutions and at home.
It is recommended to use the product individually. The solution in dropper tubes (unidoses) is intended for use within 6 hours after opening.
Performing procedures with this medical device at home does not require special training and special skills.
This product has been designed, manufactured, tested and packaged in compliance with all relevant requirements.
The manufacturer guarantees the product quality until the expiry date, provided that the conditions of transportation, packaging integrity, storage and use are observed.
Dispose of the medicinal product (including unused solution) in accordance with SanPiN 2.1.3684-21 as class A waste (epidemiologically non-hazardous waste with composition close to solid municipal waste).
Consult your healthcare professional before use